Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Pathways in HR+/HER2- Breast Cancer
NCT05736367Recruiting
- Sponsor
- Rutgers University
- Start
- Nov 2024
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial in breast cancer, sponsored by Rutgers University. Primary endpoints: Measure glycolysis metabolism dependencies using Liquid chromatography-mass spectrometry (LC-MS) and Measure glycolysis metabolism dependencies using Nuclear Magnetic Resonance (NMR) spectroscopy. Started Nov 2024; status: recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05736367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05736367.